Cargando…
COVID-19 pneumonia in a patient with adult T-cell leukemia-lymphoma
Although some patients with COVID-19 develop only mild symptoms, fatal complications have been observed among those with comorbidities. As patients with cancer are immunocompromised, they are thought to have a high risk of severe illness associated with COVID-19. We report a COVID-19 patient with ad...
Autores principales: | Hosoba, Rika, Makita, Shinichi, Shiotsuka, Mika, Kobayashi, Osamu, Nakano, Kiyoko, Muroya, Mimiko, Okada, Naoko, Suzuki, Makiko, Ida, Hanae, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Maruyama, Dai, Maeshima, Akiko Miyagi, Matsushita, Hiromichi, Yamamoto, Noboru, Ohe, Yuichiro, Iwata, Satoshi, Izutsu, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JSLRT
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810254/ https://www.ncbi.nlm.nih.gov/pubmed/32879154 http://dx.doi.org/10.3960/jslrt.20030 |
Ejemplares similares
-
The outcome of watchful waiting in patients with previously treated follicular lymphoma
por: Fujino, Takahiro, et al.
Publicado: (2022) -
Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab
por: Ito, Yuta, et al.
Publicado: (2018) -
Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin
por: Nakai, Ritsuko, et al.
Publicado: (2019) -
Clinicopathological analysis of primary refractory diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy
por: Suzuki, Tomotaka, et al.
Publicado: (2021) -
Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late relapsed tumors
por: Suzuki, Tomotaka, et al.
Publicado: (2020)